Bruce G. Allen Investments’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-2
Closed -$254 – 1124
2025
Q1
$254 Hold
2
– – ﹤0.01% 1037
2024
Q4
$288 Sell
2
-6
-75% -$860 ﹤0.01% 1037
2024
Q3
$1.19K Buy
8
+6
+300% +$860 ﹤0.01% 785
2024
Q2
$252 Sell
2
-2
-50% -$313 ﹤0.01% 936
2024
Q1
$736 Hold
4
– – ﹤0.01% 817
2023
Q4
$719 Buy
+4
New +$623 ﹤0.01% 878

Other funds holding RGEN

Bruce G. Allen Investments's RGEN Position: Q2 2025 in Review

Bruce G. Allen Investments sold out of Repligen (RGEN) in Q2 2025, closing a stake of 2 shares — an estimated $254 sold.

Bruce G. Allen Investments first reported a position in RGEN in Q4 2023 and held it in 6 quarters. The position peaked at $1.19K in Q3 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Bruce G. Allen Investments reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Bruce G. Allen Investments sold 2 Repligen shares in Q2 2025, an estimated $254.
  • Bruce G. Allen Investments first reported a position in Repligen in Q4 2023 and held it in 6 quarters.
  • Bruce G. Allen Investments's Repligen position peaked at $1.19K in Q3 2024.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Bruce G. Allen Investments's 13F filing for Q2 2025, filed 9 Jul 2025.